Sandra Kuzmich is a partner at the New York office of Frommer Lawrence & Haug LLP.

Ms. Kuzmich's practice focuses on patent litigation, primarily relating to pharmaceutical litigation under the Hatch-Waxman Act.

Prior to joining Frommer Lawrence & Haug LLP, Ms. Kuzmich spent several years in the private pharmaceutical sector working in the areas of drug metabolism and pharmacokinetics.

Ms. Kuzmich received her undergraduate degree in chemistry from Douglass College, Rutgers University, after which she received a Ph.D. in pharmacology from Yale University in 1989. The focus of her Ph.D. thesis was the mechanisms of antiviral and antineoplastic activity of modified nucleosides.

Following her graduate studies she spent four years as a postdoctoral research associate at Fox Chase Cancer Center in Philadelphia where her research dealt with the mechanisms of anticancer drug resistence in colon cancer, with a focus on the role of the glutathione S-tranferase family of enzymes in these resistance mechanisms.


Bar Admission

New York (2002)
Connecticut (2002)
Registered to practice before
U.S. Patent and Trademark Office


Douglass College, Rutgers University
(B.S., Chemistry, 1981)
Yale University
(Ph.D., Pharmacology Form, 1989)
Fordham University (J.D., 2001)


Connecticut Bar Association
New York Intellectual
Property Association
Phi Beta Kappa
New York State Bar Association
American Bar Association

Primary Office

745 Fifth Avenue
New York, New York 10151
Telephone: (212) 588-0800
Fax: (212) 588-0500

Copyright 2005 Frommer Lawrence & Haug LLP. All Rights Reserved.
Click here to view Web Site Disclaimer.